XBP1 and metabolic dysfunction-associated steatotic liver disease: Disruption of XBP1 promoted NAFLD development, likely through altering the temporal 12-h transcription of lecithin–cholesterol acyltransferase, lysophosphatidylcholine acyltransferase 3, and stearoyl-CoA desaturase 1, and through impairing phosphatidylcholine and lysophosphatidylcholines cycle, as well as fatty acid monounsaturation (73).